These findings suggest that SV supplementation counters obesity‐induced muscle atrophy and metabolic dysfunction through flavonoid‐mediated AMPK activation, supporting its potential as a safe and effective nutritional strategy for managing sarcopenic obesity. This evidence concerns the gene PRKAA2 and obesity disorder.